Valentina I. Zvyagina

Dr. Valentina I. Zvyagina


Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 December 2014 in I.P. Pavlov Russian Medical Biological Herald
Verified
Journal Article
Open access
PDF file
DMD V Medvedev
D V Medvedev
VZValentina I. Zvyagina
Valentina I. Zvyagina
MFM A Fomina
M A Fomina
To date it’s proved that the elevated homocysteine levels in the blood is an independent risk factor for a number of diseases. The animal model of rare severe form of hyperhomocysteinemia may be necessary to study aspects of homocysteine participation in damage of organs and tissues in various diseases because the effects of this pathogenetic factor will be most pronounced in such conditions. This article describes a technique for modeling in male Wistar rats a severe form of hyperhomocysteinemia by a three-week intragastric administration of methionine suspension with the addition of this amino acid in the drinking water.

9 April 2020 in I.P. Pavlov Russian Medical Biological Herald
Verified
Journal Article
Open access
PDF file
EBEduard S. Belskikh
Eduard S. Belskikh
OUOleg M. Uryasiev
Oleg M. Uryasiev
VZValentina I. Zvyagina
Valentina I. Zvyagina
SFSvetlana V. Faletrova
Svetlana V. Faletrova
Aim. To study the concentration of succinate and the activity of succinate dehydrogenase (SDH) of mononuclear blood leukocytes as markers of rapid adaptation of mitochondria to hypoxia in patients with exacerbation of chronic obstructive pulmonary disease (COPD). Materials and Methods. The study involved 58 patients with COPD and 13 conventionally healthy volunteers of 40-75 years of age. In accordance with GOLD 2018 principles of complex assessment, the patients were divided to groups B (n=18), C (n=20), D (n=20) comparable in age, FEV1 and in pack-of-cigarettes/year index. Patients of D group were characterized by more pronounced hypoxemia. Activity of SDH and concentration of succinate were determined in mononuclear leukocytes isolated from blood. Results. Patients with exacerbation of COPD divided to groups on the basis of the frequency of exacerbations and evidence of symptoms, were characterized by different severity of disorders of mitochondrial functions of mononuclear leukocytes. Patients of C group had the highest succinate concentration (428 [357;545] nmol/106 cells in I ml of suspension) and SDH activity (64[56;73] nmol of succinate/min * 106 cells of 1 ml of suspension) in mononuclear leukocytes as compared to groups B (1.43-times reduction of succinate, p0.002; 1.88-times reduction of SDH, p=0.0015) and D (2.06-times reduction of succinate, p0.0001; 4.26-times reduction of SDH, p0.0001). Patients of D group demonstrated the most pronounced reduction of markers of adaptation to hypoxia. Conclusions. A small amount of symptoms in exacerbation of COPD is associated with the highest parameters of the mechanism of rapid adaptation of mitochondria of mononuclear leukocytes to hypoxia. Existence of evident symptoms and frequent exacerbations in patents is associated with a severe frustration of mechanisms of adaptation of mitochondria to hypoxia.

7 April 2024 in I.P. Pavlov Russian Medical Biological Herald
Verified
Journal Article
Open access
PDF file
RKRoman E. Kalinin
Roman E. Kalinin
ISIgor Suchkov
Igor Suchkov
SRSergey N. Raitsev
Sergey N. Raitsev
VZValentina I. Zvyagina
Valentina I. Zvyagina
EBEduard S. Belskikh
Eduard S. Belskikh
РНРайцев Сергей Николаевич
Райцев Сергей Николаевич
INTRODUCTION: A novel coronavirus (severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2)) emerged in December 2019 and rapidly spread over the world having provoked a pandemic of respiratory disease. This highly pathogenic virus can attack the lung tissue and derange gas exchange leading to acute respiratory distress syndrome and systemic hypoxia. Hypoxic conditions trigger activation of adaptation mechanisms including hypoxia-inducible factor-1á (HIF-1á) which is involved in the regulation of the key processes, e. g, proliferation and metabolism of cells and angiogenesis. Besides, the level of HIF-1á expression is associated with the intensity of the immune response of an organism including that of the innate immunity mediating inflammatory reaction. Therefore, understanding the peculiarities of the mechanisms underlying the pathogenesis of this disease is of great importance for effective therapy of coronavirus disease 2019 (COVID-19). AIM: Analysis of the current data on HIF-1á and its effect on the pathogenesis and progression of COVID-19. The analysis of the relevant domestic and international literature sources was performed in the following sections: HIF-1á as a key factor of adaptation to hypoxia, targets for HIF-1á in the aspect of the pathogenesis of COVID-19, disorders in HIF-1á-mediated adaptation to hypoxia as an element of the pathogenesis of hyperactivation of the immune cells. CONCLUSION: HIF-1á prevents penetration of SARS-CoV-2 virus into a cell and primarily acts as the main regulator of the proinflammatory activity at the inflammation site surrounded by hypoxia. In the conditions of the deranged metabolic flexibility, a high level of HIF-1á evokes an excessive inflammatory response of the immune cells. A high HIF-1á level in cells of the inflammation focus is associated with enhanced production of the factors of angiogenesis mediating vascular permeability and capillary leakage process. This is accompanied by tissue damage and organ failure. At the same time, HIF-1á can mediate the anti-inflammatory effect through activation of adenosine receptor-dependent pathway, which is considered as a probable protection of cells and organs against damage by hyperactive immune cells.

1 January 2018 in Medical news of the North Caucasus
Verified
Journal Article
Closed access
VZValentina I. Zvyagina
Valentina I. Zvyagina
EBEduard S. Belskikh
Eduard S. Belskikh
OUOleg Uryasev
Oleg Uryasev
DMDmitriy Medvedev
Dmitriy Medvedev
VKValentina Kiseleva
Valentina Kiseleva
LTLudmila Tverdova
Ludmila Tverdova

1 May 2017 in Biomeditsinskaya Khimiya
Verified
Journal Article
Closed access
DMD.V. Medvedev
D.V. Medvedev
VZValentina I. Zvyagina
Valentina I. Zvyagina
OUO.M. Uryasev
O.M. Uryasev
EBEduard S. Belskikh
Eduard S. Belskikh
SBS.V. Bulatetskiy
S.V. Bulatetskiy
ARA.N. Ryabkov
A.N. Ryabkov
Hyperhomocysteinemia is a risk factor for many human diseases, including pulmonary pathologies. In this context much interest attracts secondary mitochondrial dysfunction, which is an important link in pathogenesis of diseases associated with hyperhomocysteinemia. The study was conducted using male Wistar rats. It was found that under conditions of severe hyperhomocysteinemia caused by administration of methionine, homocysteine was accumulated in lung mitochondria thus suggesting a direct toxic effect on these organelles. However, we have not observed any significant changes in the activity of mitochondrial enzymes involved in tissue respiration (succinate dehydrogenase) and oxidative phosphorylation (H+-ATPase) and of cytoplasmic lactate dehydrogenase. Also there was no accumulation of lactic acid in the cytoplasm. Animals with severe hyperhomocysteinemia had higher levels of lung mitochondrial protein carbonylation, decreased reserve-adaptive capacity, and increased superoxide dismutase activity. These results indicate that severe hyperhomocysteinemia causes development of oxidative stress in lung mitochondria, which is compensated by activation of antioxidant protection. These changes were accompanied by a decrease in the concentration of mitochondrial nitric oxide metabolites. Introduction to animals a nonselective NO-synthase inhibitor L-NAME caused similar enhancement of mitochondrial protein carbonylation. It demonstrates importance of reducing bioavailability of nitric oxide, which is an antioxidant in physiological concentrations, in the development of oxidative stress in lung mitochondria during hyperhomocysteinemia. Key words: hyperhomocysteinemia, nitric oxide, lung, oxidative stress, mitochondria

1 March 2022 in Journal of Evolutionary Biochemistry and Physiology
Verified
Journal Article
Closed access
PDF file
VZValentina I. Zvyagina
Valentina I. Zvyagina
EBE. S. Belskikh
E. S. Belskikh
The state of protein carbonylation with the determination of the adaptive reserve potential and analysis of the proportion of primary and secondary markers of oxidative protein damage in rat epididymal mitochondria due to oxidative stress induced by hyperhomocysteinemia and L-NAME-mediated inhibition of NO synthases was comparatively assessed in this study. It was demonstrated that an increase in oxidative modification of mitochondrial proteins induced by high homocysteine levels is accompanied by a decrease in the concentration of NO (II) metabolites and resembles the changes induced by a nonselective NO synthase inhibitor L-NAME. These changes are accompanied by signs of secondary mitochondrial dysfunction in the form of a decreased activity of succinate dehydrogenase, H+-ATPase, and lactate dehydrogenase, as well as an increase in lactate and a decrease in carnitine levels. At the same time, the manifestation of changes in the above parameters was different in mitochondria isolated from the head and tail of the rat epididymis. In the head, there were metabolic shifts associated with changes in bioenergetic processes, namely an increase in lactate concentration paralleled by a decrease in lactate dehydrogenase, succinate dehydrogenase, and H+-ATPase activities in mitochondria. In the tail, there were observed the effects that were basically protective and aimed at maintaining the functional activity of the epididymal tail tissues under conditions of oxidative stress.